A couple of weeks ago, I wrote about how post-vaccine fatigue had me thinking about multiple myeloma relapse. I mentioned how worried my…

A Phase 2 trial of a four-drug regimen including Sarclisa Escena (isatuximab-irfc) showed promising treatment responses in people ages 65 and older with newly…

Early treatment with Jakafi (ruxolitinib) is no better than older therapies at inducing a complete response in those with polycythemia vera (PV), but it…